Syros Pharmaceuticals Inc (NASDAQ: SYRS) is -40.82% lower on its value in year-to-date trading and has touched a low of $0.07 and a high of $6.93 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The SYRS stock was last observed hovering at around $0.09 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $0.14, the stock is -5.06% and -25.17% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 691.04 million and changing 48.47% at the moment leaves the stock -94.01% off its SMA200. SYRS registered -98.04% loss for a year compared to 6-month loss of -91.02%.
The stock witnessed a -21.43% gain in the last 1 month and extending the period to 3 months gives it a -42.47%, and is 60.00% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 43.25% over the week and 19.85% over the month.
Syros Pharmaceuticals Inc (SYRS) has around 68 employees, a market worth around $3.65M and $0.39M in sales. Profit margin for the company is -25340.67%. Distance from 52-week low is 108.27% and -98.04% from its 52-week high. The company has generated returns on investments over the last 12 months (-210.27%).
The EPS is expected to grow by 74.11% this year.
Syros Pharmaceuticals Inc (SYRS) Top Institutional Holders
The shares outstanding are 26.83M, and float is at 23.67M with Short Float at 3.86%.
Syros Pharmaceuticals Inc (SYRS) Insider Activity
#####
Still, SEC filings show that on Dec 30 ’24, AKKARAJU SRINIVAS (Director) Proposed Sale 9,333 shares at an average price of $0.25 for $2306.0. The insider now directly holds shares of Syros Pharmaceuticals Inc (SYRS).
